Niharika B. Mettu
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 15
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 5
-
- Cancer Genomics and Diagnostics 8
-
- Genetic factors in colorectal cancer 4
-
- Advanced Breast Cancer Therapies 3
-
- DNA Repair Mechanisms 6
-
- Cancer Research and Treatments 3
- Co-authors
- Herbert I. HurwitzDonna NiedzwieckiPatrick M. BolandMarwan FakihAndrew B. NixonHeinz‐Josef LenzTanios Bekaii‐SaabOxana Crysler
- Journals
- Journal of Clinical Oncology (15 papers)SHILAP Revista de lepidopterología (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Niharika B. Mettu
39 papers receiving 495 citations
Peers
Comparison fields: 5 of 57
- Oncology 374
- Cancer Research 77
- Pathology and Forensic Medicine 87
- Immunology 90
- Pulmonary and Respiratory Medicine 87
Countries citing papers authored by Niharika B. Mettu
This map shows the geographic impact of Niharika B. Mettu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niharika B. Mettu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niharika B. Mettu more than expected).
Fields of papers citing papers by Niharika B. Mettu
This network shows the impact of papers produced by Niharika B. Mettu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niharika B. Mettu. The network helps show where Niharika B. Mettu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Niharika B. Mettu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 15 | |
| 14 | 2021 | 42 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 33 | |
| 17 | 2020 | 77 | |
| 18 | 2019 | 7 | |
| 19 | Use of molecular biomarkers to inform adjuvant therapy for colon cancer. | 2013 | 10 |
| 20 | 2011 | 1 |
About Niharika B. Mettu
Niharika B. Mettu is a scholar working on Oncology, Cancer Research and Biological Psychiatry, having authored 40 papers that have together received 507 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (15 papers), Cancer Immunotherapy and Biomarkers (8 papers), Cancer Genomics and Diagnostics (8 papers), DNA Repair Mechanisms (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (4 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Oncology (374 citations), Cancer Research (77 citations) and Pathology and Forensic Medicine (87 citations). Niharika B. Mettu has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Herbert I. Hurwitz, Donna Niedzwiecki, Patrick M. Boland, Marwan Fakih, Andrew B. Nixon, Heinz‐Josef Lenz, Tanios Bekaii‐Saab, Oxana Crysler, Christina Wu and Þorvarður R. Hálfdánarson. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.